Procurement Summary
Country : USA
Summary : NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)
Deadline : 18 Dec 2020
Other Information
Notice Type : Tender
TOT Ref.No.: 20486237
Document Ref. No. : PAR-18-643
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV
Tender Details
Tender are invited for NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)
CFDA Number : 93.233 -- National Center on Sleep Disorders Research93.837 -- Cardiovascular Diseases Research93.838 -- Lung Diseases Research93.839 -- Blood Diseases and Resources Research93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Dec 18, 2020
Posted Date : Feb 08, 2018
Description: This Funding Opportunity Announcement (FOA) seeks to accelerate the pace and expand the breadth of scientific research on the clinical course, prevention and treatment of diseases within NHLBI``s mission by leveraging ongoing clinical research studies through ancillary studies. This FOA invites research project applications to conduct ancillary studies to clinical research studies, including clinical trials, prospective observational studies, and/or registries. Applications submitted to this FOA must propose to collect new information and/or biological samples from participants of the ongoing parent study, and must address new research questions that are beyond those specified in the approved protocol of the parent study and are within the scientific mission of the NHLBI. Applications submitted in response to this FOA cannot be used to extend the duration of the parent study or to provide funds solely for parent study enrollment, capitation, or study performance.
Documents
Tender Notice